Predictive oncology stock.
Third, all of these shares are below a certain price of $ 3. As a result, they are relatively inexpensive, although the definition of penny stocks has changed over time. It basically includes all stocks traded for less than $ 5, although there are no hard and fast rules to talk about. They are here: ObsEva (NASDAQ: OBSV) Predictive oncology ...
Jul 18, 2023 · Predictive Oncology Inc. PITTSBURGH, July 18, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and ... Real-time quotes, advanced visualizations, historical statements, and much more. Selling, General and Administrative Excl. Other. POAI - Predictive Oncology Inc - Stock screener for investors and traders, financial visualizations.
Predictive Oncology Inc. 91 43rd Street. Suite 110. Pittsburgh, Pennsylvania 15201. Phone 1 412 432-15000. Industry Medical Equipment/Supplies. Sector Health Care/Life Sciences.Feb 24, 2021 · Predictive Oncology includes various subsidiaries in the drug development and formulation space, as well as a legacy medical device business generating revenues, but this article focuses on their ... Your vote is important and easy to cast. Vote Now! Please enter your control number to view/cast your vote. Control Number. Log In ...
Predictive Oncology recorded revenue of $490,110 in the second quarter of 2023, compared to $371,591 in 2022. Sales of Streamway related products and services by our Eagan operating segment were ...
Discover historical prices for POAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Predictive Oncology Inc. stock was issued. Nov 8, 2023 · Leading-edge solution. Predictive Oncology has launched a breakthrough solution at a pivotal time in drug discovery that enables pharmaceutical and biotech companies to expedite drug development and speed time to market. The company’s novel platform technology valued at $400M+ has the power to impact a billion-dollar biopharmaceutical ... The reverse stock split will reduce the number of shares of Predictive Oncology’s common stock outstanding from 79,597,181 shares to approximately 3,979,860 shares, subject to adjustment for the ...Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023 GlobeNewswire 11d 3 AI Stocks Worth Buying Now for Multibagger ...Daniel Handley POAI stock SEC Form 4 insiders trading. Daniel has made over 4 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of POAI stock worth $2,460 on 15 December 20226,000 units of POAI stock worth $2,460 on 15 December 2022
The estimated Net Worth of Robert L Myers is at least $351 ezer dollars as of 2 December 2022. Mr Myers owns over 8,795 units of Predictive Oncology stock worth over $23,211 and over the last 6 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.
Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre ...
May 16, 2022 · Predictive Oncology Inc. EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused ... On average, Predictive Oncology executives and independent directors trade stock every 71 days with the average trade being worth of $99,350. The most recent stock trade was executed by Robert L Myers on 25 September 2023, trading 1,667 units of POAI stock currently worth $5,334.Aug 10, 2023 · Predictive Oncology Inc. 2.9722. +0.0322. +1.10%. Company to host investor call and webcast today, August 10th, at 5:30pm EDTPITTSBURGH, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology ... Mar 16, 2023 · EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series F Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p ... Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre ...
0.73%. $39.94B. Astellas Pharma Inc. -4.37%. ¥3.42T. PYXS | Complete Pyxis Oncology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.The estimated Net Worth of Daniel E Handley is at least $351 Thousand dollars as of 15 December 2022. Daniel Handley owns over 6,000 units of Predictive Oncology stock worth over $350,584 and over the last 3 years he sold POAI stock worth over $0. In addition, he makes $0 as Director at Predictive Oncology.Predictive Oncology includes various subsidiaries in the drug development and formulation space, as well as a legacy medical device business generating revenues, but this article focuses on their ...FOSTER CITY, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (“Notable”) (Nasdaq: NTBL), a clinical stage therapeutic platform company …The estimated Net Worth of J Melville Engle is at least $987 Thousand dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $984,422 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.
What this means: Predictive Oncology Inc (POAI) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives POAI a rank of 10. Our methodology considers analysis of the company's financial situation and how it has traded recently. POAI rank of 10 means that it ranks below 90% of stocks.Predictive Oncology Inc stock performance at a glance. Check Predictive Oncology Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.
Predictive Oncology Inc. 2.9722. +0.0322. +1.10%. Company to host investor call and webcast today, August 10th, at 5:30pm EDTPITTSBURGH, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology ...Predictive Oncology (POAI) Quote Overview ... It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.Track Predictive Oncology Inc (POAI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Predictive Oncology Inc. EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused ...Big data and predictive analytics have immense potential to improve risk stratification, particularly in data-rich fields like oncology. This article reviews the literature published on use cases and challenges in applying predictive analytics to improve risk stratification in oncology. We characterized evidence-based use cases of predictive …Raymond Vennare POAI stock SEC Form 4 insiders trading. Raymond has made over 1 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently Raymond bought 5,000 units of POAI stock worth $2,600 on 2 December 2022.. The largest trade Raymond's ever made was buying 5,000 units …Predictive Oncology Inc stock performance at a glance. Check Predictive Oncology Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. Quotes Summary Real-Time After-Hours Pre-Market Key Data Bid Price and Ask Price The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is …
Predictive Oncology Inc. Weekly Stock List Management's ability to "raise guidance" can often be a catalyst for market-beating returns in the quarters ahead. The third-quarter earnings season is ...
PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that ...
Track Predictive Oncology Inc (POAI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors The estimated Net Worth of Carl I. Schwartz is at least 4.75 百万$ dollars as of 22 October 2020. Dr Schwartz owns over 640 units of Predictive Oncology stock worth over 4,318,394$ and over the last 7 years he sold POAI stock worth over 544$. In addition, he makes 433,000$ as CEO & Director at Predictive Oncology.December 01, 2021 at 08:31 am EST. EAGAN, Minn., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies, today announced the acquisition of zPREDICTA, a company pioneering tumor-specific in vitro 3D cell culture models ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Predictive Oncology share forecasts, stock quote and buy / sell signals below. According to present data Predictive Oncology's POAI shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Tesla’s stock is predicted to increase in value in 2015, according to Forbes. In January 2015, Forbes noted that Tesla Motors, Inc.Predictive Oncology Inc (POAI) Message Board - Company Name: Predictive Oncology Inc, Stock Symbol: POAI, Industry: Medical - Healthcare - Total Posts: 4357 - Last Post: 07/15/2023 01:24:11 PM - company/specific stock board. Support: 888-992-3836 Home NewsWire SubscriptionsFOSTER CITY, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (“Notable”) (Nasdaq: NTBL), a clinical stage therapeutic platform company …Apr 24, 2023 · Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre ... Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023 GlobeNewswire 11d 3 AI Stocks Worth Buying Now for Multibagger ...Real-time quotes, advanced visualizations, historical statements, and much more. Selling, General and Administrative Excl. Other. POAI - Predictive Oncology Inc - Stock screener for investors and traders, financial visualizations.12 brokers have issued 12-month price objectives for Rain Oncology's stock. Their RAIN share price targets range from $11.00 to $24.00. On average, they anticipate the company's stock price to reach $17.00 in the next year. This suggests a possible upside of 1,431.5% from the stock's current price.Effective March 16, 2023, Predictive Oncology and Cancer Research Horizons, the world’s largest private funder of cancer research, have partnered to drive the development of oncology drugs utilizing Predictive Oncology’s PEDAL platform that pairs artificial intelligence (AI) with the world’s largest biobank of tumor samples;
Press Releases. Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update. Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital. Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023.The oncology industry is expected to grow considerably in 2022, driven by the rising occurrence of cancer in the U.S. population. Furthermore, increasing investments by biopharmaceutical companies and the government should fuel the industry's growth. Given the industry's bright growth prospects, Wall Street analysts expect the stocks of …Find the latest Ikena Oncology, Inc. (IKNA) stock quote, history, news and other vital information to help you with your stock trading and investing.The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ...Instagram:https://instagram. best growth stocks with dividendsotcmkts vrnoftop stock performers todaycybertruck msrp EAGAN, Minn., April 04, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and ...May 16, 2022 · Predictive Oncology Inc. EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused ... td ameritrade how to short a stockessents Complete Predictive Oncology Inc. stock information by Barron's. View real-time POAI stock price and news, along with industry-best analysis.The estimated Net Worth of Carl I. Schwartz is at least $1.17 Milion dollars as of 22 October 2020. Dr Schwartz owns over 640 units of Predictive Oncology stock worth over $741,217 and over the last 7 years he sold POAI stock worth over $544. In addition, he makes $433,000 as CEO & Director at Predictive Oncology. sofi stock buy or sell 3 analysts have issued 1 year price objectives for Surface Oncology's stock. Their SURF share price targets range from $3.00 to $6.00. On average, they predict the company's share price to reach $4.50 in the next year. This suggests a possible upside of 320.6% from the stock's current price. View analysts price targets for SURF or view …Aug 11, 2022 · An increase of cash and equivalents from $25 million on March 31, 2022, to $28 million at quarter end, which represents a positive change of 12%. Q2 2022 financial results. Predictive Oncology’s ...